Sexual Risk Behavior Among HIV-Uninfected Men Who Have Sex With Men Participating in a Tenofovir Preexposure Prophylaxis Randomized Trial in the United States

Objective:To evaluate for changes in sexual behaviors associated with daily pill use among men who have sex with men (MSM) participating in a preexposure prophylaxis trial. Design:Randomized, double-blind, placebo-controlled trial. Participants were randomized 1:1:1:1 to receive tenofovir disoproxil fumarate or placebo at enrollment or after a 9-month delay and followed for 24 months. Methods:Four hundred HIV-negative MSM reporting anal sex with a man in the past 12 months and meeting other eligibility criteria enrolled in San Francisco, Atlanta, and Boston. Sexual risk was assessed at baseline and quarterly visits using Audio Computer-Assisted Self-Interview. The association of pill taking with sexual behavior was evaluated using logistic and negative-binomial regressions for repeated measures. Results:Overall indices of behavioral risk declined or remained stable during follow-up. Mean number of partners and proportion reporting unprotected anal sex declined during follow-up (P < 0.05), and mean unprotected anal sex episodes remained stable. During the initial 9 months, changes in risk practices were similar in the group that began pills immediately vs. those in the delayed arm. These indices of risk did not differ significantly after initiation of pill use in the delayed arm or continuation of study medication in the immediate arm. Use of poppers, amphetamines, and sexual performance–enhancing drugs were independently associated with one or more indices of sexual risk. Conclusions:There was no evidence of risk compensation among HIV-uninfected MSM in this clinical trial. Monitoring for risk compensation should continue now that preexposure prophylaxis has been shown to be efficacious in MSM and other populations and will be provided in open-label trials and other contexts.

[1]  Emily C. Pike,et al.  Investigating a Sexual Network of Black Men Who Have Sex With Men: Implications for Transmission and Prevention of HIV Infection in the United States , 2012, Journal of acquired immune deficiency syndromes.

[2]  E. Vittinghoff,et al.  Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men , 2012, PloS one.

[3]  M. Golden,et al.  Failure of Serosorting to Protect African American Men Who Have Sex With Men From HIV Infection , 2012, Sexually transmitted diseases.

[4]  A. Lansky,et al.  Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. , 2012, MMWR. Morbidity and mortality weekly report.

[5]  Katrien Fransen,et al.  Preexposure prophylaxis for HIV infection among African women. , 2012, The New England journal of medicine.

[6]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[7]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[8]  David R. Holmes.  FDA paves the way for pre-exposure HIV prophylaxis , 2012, The Lancet.

[9]  J. Baeten,et al.  Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence , 2012, Current opinion in infectious diseases.

[10]  Ruiguang Song,et al.  Estimated HIV Incidence in the United States, 2006–2009 , 2011, PloS one.

[11]  A. Lansky,et al.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. , 2011, MMWR. Morbidity and mortality weekly report.

[12]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[13]  Lynn Morris,et al.  Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.

[14]  D. Operario,et al.  Pre-exposure Prophylaxis State of the Science: Empirical Analogies for Research and Implementation , 2010, Current HIV/AIDS reports.

[15]  E. Vittinghoff,et al.  Amphetamine-group substances and HIV , 2010, The Lancet.

[16]  M. Golden,et al.  Why the Wait? Delayed HIV Diagnosis among Men Who Have Sex with Men , 2010, Journal of Urban Health.

[17]  R. Walensky,et al.  HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Pai-Lien Chen,et al.  Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial , 2008, Sexually transmitted diseases.

[19]  G. Garnett,et al.  Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness , 2008, AIDS.

[20]  Laith J. Abu-Raddad,et al.  Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa , 2008, PLoS ONE.

[21]  J. Dik F. Habbema,et al.  The Impact of Pre-Exposure Prophylaxis (PrEP) on HIV Epidemics in Africa and India: A Simulation Study , 2008, PloS one.

[22]  S. Kalichman,et al.  Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies , 2007, Current HIV/AIDS reports.

[23]  R. Bakeman,et al.  Explaining disparities in HIV infection among black and white men who have sex with men: a meta-analysis of HIV risk behaviors , 2007, AIDS.

[24]  Stephen Moses,et al.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial , 2007, The Lancet.

[25]  S. Buchbinder,et al.  Risk factors for HIV infection among men who have sex with men , 2006, AIDS.

[26]  J. Shelton,et al.  Risk compensation: the Achilles' heel of innovations in HIV prevention? , 2006, BMJ : British Medical Journal.

[27]  Emmanuel Lagarde,et al.  Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial , 2005, PLoS medicine.

[28]  E. Vittinghoff,et al.  Sexual Risk, Nitrite Inhalant Use, and Lack of Circumcision Associated With HIV Seroconversion in Men Who Have Sex With Men in the United States , 2005, Journal of acquired immune deficiency syndromes.

[29]  S. Buchbinder,et al.  HIV Sexual Risk Behavior Over 36 Months of Follow-Up in the World's First HIV Vaccine Efficacy Trial , 2005, Journal of acquired immune deficiency syndromes.

[30]  Atlanta,et al.  Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. , 2010, MMWR. Morbidity and mortality weekly report.

[31]  T. Finlayson,et al.  Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. , 2010, MMWR. Morbidity and mortality weekly report.